Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-25 @ 3:30 AM
NCT ID:
NCT00694005
Eligibility Criteria:
Inclusion Criteria:
* Clinical
* Patients with angina and documented ischemia or patients with documented silent ischemia
* Patients who are eligible for intracoronary stenting
* Age \>18 years, \<75 ages
* Angiographic
* De novo lesion located in a major bifurcation point with the MEDINA classification type 1.1.0, 1.0.0, or 0.1.0
* Main vessel : \>= 2.5 mm in vessel size, \>= 50% in diameter stenosis and =\< 50 mm in lesion length by visual estimation, in which the lesion is covered with =\< 2 stents
* Side branch :\>= 2.0 mm in vessel size and \< 50% diameter stenosis by visual estimation
Exclusion Criteria:
* History of bleeding diathesis or coagulopathy
* Pregnant
* Known hypersensitivity or contra-indication to contrast agent, heparin, sirolimus, paclitaxel and zotarolimus
* Limited life-expectancy (less than 1 year) due to combined serious disease
* ST-elevation acute myocardial infarction =\< 2 weeks
* Characteristics of lesion:
* Left main disease
* In-stent restenosis
* Graft vessels
* TIMI flow =\< grade 2 in the side branch
* Chronic total occlusion
* Renal dysfunction, creatinine \>= 2.0mg/dL
* Contraindication to aspirin, clopidogrel or cilostazol
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00694005
Study Brief:
Protocol Section:
NCT00694005